Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities. - sprookjes - yvandenbroek - TriplyDB

Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.

Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.

http://www.wikidata.org/entity/Q34434622

about

Atherosclerosis in psoriatic disease: latest evidence and clinical implications Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients.Chronic, not acute, skin-specific inflammation promotes thrombosis in psoriasis murine models Concomitant Sleep Disorders Significantly Increase the Risk of Cardiovascular Disease in Patients with Psoriasis Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab Therapy The Association between Psoriasis Area and Severity Index and Cardiovascular Risk Factor in Korean Psoriasis Patients The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.Treating Psoriasis During Pregnancy: Safety and Efficacy of Treatments.Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.Reducing patient copayment levels for topical and systemic treatments in plaque psoriasis as a case for evidence-based, sustainable pharmaceutical policy change in Greece.Abnormal regulation of fibronectin production by fibroblasts in psoriasis.IL-17 Blockade in Psoriasis: Friend or Foe in Cardiovascular Risk?The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins.Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities.Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).Identification of proresolving and inflammatory lipid mediators in human psoriasis Potential Immunological Links Between Psoriasis and Cardiovascular Disease.Clinical factors predicting the therapeutic response to ustekinumab in patients with moderate to severe chronic plaque psoriasis

P2860

Q26783501-96BD303E-B7D5-45C6-83AC-C5B51239D86F Q35860158-5E80138E-816E-4282-BFC8-11A40989F801 Q35870923-0BCA13B6-A196-4EAC-88B5-A493DCE2BD95 Q35888911-CBE670CD-E9CD-48B6-9065-72C983FBB062 Q36326833-C9B1C8EF-12A5-475E-A814-77A777467BDD Q36936706-7C56E9C7-2A96-4122-BB21-FE11828C7844 Q36946016-7BB9745C-ABB0-410D-9BC3-74032E45E70C Q38341507-BDA54C4E-F014-41D0-9239-5C6BD59CB067 Q38543325-1C5F9F41-B9B6-4FD2-9016-3D889ABE8051 Q38749538-2A21F133-9A90-47A7-8110-D623FA243F1C Q39748220-5413E313-4CD5-4BDA-A3FB-EC4E1D49F052 Q40427057-F53F7505-5A32-4D5D-B45A-794DEADC2F20 Q41104626-FE1C7666-392F-4F91-A660-BBE80CB90D8F Q41459873-3FBD0C1D-58DC-4ACC-86EE-860AACCB80EE Q47704613-ADA5723D-A2D4-4C37-81A2-9F3ABDE2EBBF Q48122586-ED0EB626-0E4F-4F6C-B8FD-0773A2C5C4D4 Q48239956-CFC4F52F-79CF-4197-A5A9-C3795B956700 Q54592078-7E8F1B20-548B-4F84-8458-B7F4682C77AA Q55270893-606F4A6E-D172-420E-9FC0-3FEBA63AC95B Q56943584-9D31A285-6414-48D5-9E14-D2FBB8357153

P2860

Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities.

http://www.wikidata.org/entity/Q34434622

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Accumulating evidence for the ...... ascular-related comorbidities.

@ast

Accumulating evidence for the ...... ascular-related comorbidities.

@en

Accumulating evidence for the ...... ascular-related comorbidities.

@nl

type

label

Accumulating evidence for the ...... ascular-related comorbidities.

@ast

Accumulating evidence for the ...... ascular-related comorbidities.

@en

Accumulating evidence for the ...... ascular-related comorbidities.

@nl

prefLabel

Accumulating evidence for the ...... ascular-related comorbidities.

@ast

Accumulating evidence for the ...... ascular-related comorbidities.

@en

Accumulating evidence for the ...... ascular-related comorbidities.

@nl

P1433

Q34434622-D7BDB97F-381E-429C-A2ED-761458C0F86A

P1476

Q34434622-3E5E4564-FCBC-4FFA-8997-4446B9B35033

P2093

Q34434622-301D7006-02E4-49B6-A630-BFFBEECCE53F

Q34434622-360B0263-B725-40D6-AB8D-5018EAAA0697

Q34434622-408DC142-D6A4-4BE4-ADE9-B6B67166E706

Q34434622-8A250321-2610-48C6-A4A7-CFF61783F5BF

Q34434622-94F37FFE-4FE9-4BEC-B4E7-4A7AA98ADF9B

Q34434622-A6E922AB-0F84-408E-92B8-13B3AC8E411E

Q34434622-F5EBA8A1-D083-4695-BAFD-6A61FFC4DC2F

P2860

Q34434622-12FBD387-086E-420E-A37B-CDCD45DAB8EB

Q34434622-2655F568-0CC2-4288-BE4F-38D700D03FA0

Q34434622-2EE61805-1F97-42C6-95FD-DF00AB405518

Q34434622-33D819CE-2D8D-4D2C-94EE-F66EA235F731

Q34434622-40B5110D-72A6-434A-980E-E3D29DDE5129

Q34434622-41C692C1-F985-4DA2-BC31-4A78AC156EA1

Q34434622-479E4622-D33D-4BC0-B648-E2680BED5E03

Q34434622-4C318216-196E-47D5-ACC3-79E446C641AE

Q34434622-4FA7C2CB-ABAA-4E2B-8B32-4CAB24E3A4AC

Q34434622-652BE3F7-0BFE-4CC8-96F3-F5406D18572C

P304

Q34434622-54C506B9-5040-44E8-8B3C-966EA2C1A340

P31

Q34434622-5B802298-C965-47DB-9559-3EABB59D9EF3

P356

Q34434622-745C3E37-0A80-4D75-837A-A25B9F202905

P407

Q34434622-5A05C457-F9A3-4C97-B8F9-53E7DC0616E7

P433

Q34434622-F5A89A67-F0D7-48AF-83C2-574BC15B7445

P478

Q34434622-064435C9-4C38-499E-A6D3-ADDB74E3591B

P50

Q34434622-D4EE7A7D-939B-4112-BB99-A111190C4C44

P577

Q34434622-225E76E1-5D60-47E9-B3FF-2887CF30EF10

P5875

Q34434622-76BEA82A-1034-4D93-A52A-6CB43E9A2414

P698

Q34434622-885BC0CB-56C4-4D7E-B6F4-9C500D49218B

P921

Q34434622-B78BE709-8BF6-4736-BCE1-5FA685DE59AC

P932

Q34434622-E8E621B5-B630-465C-8EA2-C2A6C59326EF

P356

J.AMJMED.2014.08.008

P1433

The American Journal of Medicine

P1476

Accumulating evidence for the ...... ascular-related comorbidities.

@en

P2093

Abrar A Qureshi

http://www.w3.org/2001/XMLSchema#string

Bruce Strober

http://www.w3.org/2001/XMLSchema#string

James G Krueger

http://www.w3.org/2001/XMLSchema#string

Johann E Gudjonsson

http://www.w3.org/2001/XMLSchema#string

Julia Shlyankevich

http://www.w3.org/2001/XMLSchema#string

Nehal N Mehta

http://www.w3.org/2001/XMLSchema#string

Paul W Tebbey

http://www.w3.org/2001/XMLSchema#string

P2860

Personal omics profiling reveals dynamic molecular and medical phenotypes

Experimental endotoxemia induces adipose inflammation and insulin resistance in humans.

Vascular inflammation in psoriasis localizes to the arterial wall using a novel imaging technique.

The risk of stroke in patients with psoriasis

Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis.

Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease

Polymorphisms of the IL12B and IL23R genes are associated with psoriasis.

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

Chronic skin-specific inflammation promotes vascular inflammation and thrombosis.

Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis

P304

1148-1153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJMED.2014.08.008

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Alexandra Boer Kimball

P577

2014-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264986823

http://www.w3.org/2001/XMLSchema#string

P698

25149424

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

4259841

http://www.w3.org/2001/XMLSchema#string